Table 2.
Detection of lymph node metastases in patients by 68Ga-PSMA PET–CT and PET–MRI with biochemically recurrent prostate cancer
| Study | Patient-based Analysis | Lesion-based Analysis | |||||
|---|---|---|---|---|---|---|---|
| Patient number | LN positive patient | PET–CT a | PET–MRI a | LN positive lesion | PET–CT b | PET–MRI b | |
| Afshar-Oromieh et al 49 | 20 | 11 | 100% | 100% | 49 | 100% | 100% |
| Freitag et al 48 | 26 | 20 | 100% | 100% | 64 | 98% | 100% |
| Lütje et al 32 | 25 | 14 | 93% | 100% | 24 | 83% | 96% |
| Guberina et al 50 | 93 | 103 | 95% | 98% | |||
LN, Lymph node.
a
Patient-based detection rate.
b
Lesion-based detection rate.